Healthcare

Image

Global Cell Counting Devices Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Jul 2023
  • Global
  • 350 Pages
  • No of Tables: 50
  • No of Figures: 250

Global Cell Counting Devices Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 19.20 Billion
Diagram Market Size (Forecast Year) USD 33.00 Billion
Diagram CAGR %

Global Cell Counting Devices Market, By Product type (Consumables and Accessories, (Reagents, Assay Kits, Microplates, and Accessories), Instruments (Spectrophotometers, Flow Cytometers, Hematology Analyzers, and Cell Counters), Application (Research Applications, Cancer Research, Immunology Research, Neurology Research, Stem Cell Research, Clinical and Diagnostic Applications, Industrial Applications, and Other Research Applications), End-User (Hospitals, Diagnostic Centers, Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and Others) - Industry Trends and Forecast to 2030.

Cell Counting Devices Market Analysis and Size:

The increasing prevalence of chronic diseases and technological advancements in cell counting devices have significantly improved the design and functionality of the market and have carved the way for the growth of the cell counting device market. The market for cell counting devices has been growing steadily due to several factors. Firstly, a growing emphasis on personalized medicine has been a driver in the market. Additionally, there is an increasing geriatric population, which contributes to the cell-counting device market.

Data Bridge Market Research analyses that the market, which was USD 19.2 billion in 2022, would rocket up to USD 33 billion by 2030 and is expected to undergo a CAGR of 7.2% during the forecast period. This indicates that the consumables and accessories segment dominates the product type segment of the cell counting device market owing to the advancements in technology that have led to the development of rapid cell counting devices and treatments for various use. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cell Counting Devices Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Product type (Consumables and Accessories, (Reagents, Assay Kits, Microplates, and Accessories), Instruments (Spectrophotometers, Flow Cytometers, Hematology Analyzers, and Cell Counters), Application (Research Applications, Cancer Research, Immunology Research, Neurology Research, Stem Cell Research, Clinical and Diagnostic Applications, Industrial Applications, and Other Research Applications), End-User (Hospitals, Diagnostic Centers, Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and Others)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, rest of Middle East & Africa. 

Market Players Covered

DeNovix Inc.(U.S.), CytoSMART Technologies B.V (Netherlands), Corning Incorporated (India), Merck KGaA(Germany), GENERAL ELECTRIC COMPANY (U.S.), Thermo Fisher Scientific Inc (U.S.), PerkinElmer Inc (India), Tecan Trading AG (Switzerland), BD (U.S.), Biotek Instruments Inc (U.S.), Danaher(U.S.), Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd (U.S.), Cadmus Distribution Group Limited (U.S.), Sysmex Corporation (Japan), Abbott (U.S.), Agilent Technologies Inc (U.S.), Siemens Healthcare Private Limited (U.S.)

Market Opportunities

  • Increasing research and development activities:
  • Growing geriatric population

Market Definition

The global cell counting devices market refers to the market for instruments and devices that are used to count and analyze cells in various biological samples. These devices are designed to provide accurate and reliable measurements of cell concentration, viability, and other cellular characteristics.

Cell counting devices are widely used in research laboratories, diagnostic centers, pharmaceutical and biotechnology companies, and clinical settings. They are crucial in various applications, including basic research, drug discovery, clinical diagnostics, stem cell research, and regenerative medicine.

Global Cell Counting Devices Market Dynamics

Drivers

  • Increasing prevalence of chronic diseases

The rising incidence of chronic diseases such as cancer, cardiovascular disorders, and infectious diseases has increased demand for cell counting devices. These devices are crucial in assessing disease progression, monitoring treatment efficacy, and studying cell behavior, thereby driving market growth.

  • Rising awareness and diagnosis

As awareness about oral health and its impact on overall well-being increases, more people seek medical attention for oral conditions such as atrophic glossitis. Improved diagnostic techniques and access to healthcare services contribute to the identification and diagnosis of atrophic glossitis cases, driving the demand for treatment options.

  • Technological advancements in cell counting devices:

The continuous advancements in technology have resulted in the development of innovative cell-counting devices with improved accuracy, precision, and ease of use. These advancements, including the integration of artificial intelligence and automation, have enhanced the efficiency and reliability of cell counting, further propelling the market growth.

  • Growing emphasis on personalized medicine

Personalized medicine aims to provide tailored treatments based on an individual's genetic makeup and cellular characteristics. Cell counting devices are crucial in analyzing patient samples and determining appropriate treatment strategies. The increasing focus on personalized medicine drives the global demand for cell counting devices.

Opportunities

  • Increasing research and development activities:

The expanding research and development activities in pharmaceuticals, Biotechnology, and life sciences are driving the demand for cell counting devices. These devices are essential in various research applications, including drug discovery, stem cell research, and regenerative medicine, fueling market growth.

  • Growing geriatric population

The global geriatric population is increasing, increasing the prevalence of age-related diseases. Cell counting devices are extensively used to diagnose and manage these conditions, contributing to market growth.

Restraints

  • High cost of cell counting devices:

Cell counting devices can be expensive, especially advanced automated systems. The high cost of these devices can limit their adoption, particularly in developing regions and smaller research laboratories with budget constraints.

Challenges/Restraints

  • Ethical Considerations

In certain research areas, such as stem cell research, there may be ethical concerns regarding using cell counting devices. This can create barriers to adoption and limit the market potential in those specific fields.

This Global Cell Counting Devices Market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cell counting devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In December 2022, Merck KGaA, a leading science and technology company, announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., U.S., to discover novel antibody-drug conjugates (ADCs) leveraging Mersana’s proprietary Immunosynthen STING-agonist ADC platform, directed against up to two targets
  • In May 2023, Abbott announced a series of new programs within its multi-million-dollar initiative to increase diversity in clinical trials and improve care among under-represented populations. The new additions to Abbott's Diversity in Clinical Trials initiative build on the partnerships, scholarships, and the focus on diversified participants in the company's clinical trials during the first year

Global Cell Counting Devices Market Scope

The market is segmented on the basis of product type, application, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

By Product Type

  • Consumables and Accessories
  • Reagents
  • Assay Kits
  • Microplates
  • Accessories
  • Instruments
  • Spectrophotometers
  • Flow Cytometers
  • Hematology Analyzers
  • Cell Counters

By Application

  • Research Applications
  • Cancer Research
  • Immunology Research
  • Neurology Research
  • Stem Cell Research
  • Clinical and Diagnostic Applications
  • Industrial Applications
  • Other Research Applications

End user

  • Hospitals
  • Diagnostic Centers
  • Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Others

Global Cell Counting Devices Market regional analysis/insights

The market is analysed and market size insights and trends are provided product type, application, and end user as referenced above.

The countries covered in the Global Cell Counting Devices Market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, rest of Middle East & Africa. 

North America dominates the cell counting device market due to the presence of major key players, high disposable income, high healthcare expenditure, and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The global cell counting devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global cell counting devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global cell counting devices market. The data is available for historic period 2010-2020.

Competitive Landscape and global cell counting devices market share Analysis

The global cell counting devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global cell counting devices market.

Some of the major players operating in the global cell counting devices market are:

  • DeNovix Inc.(U.S.)
  •  CytoSMART Technologies B.V (Netherlands)
  •  Corning Incorporated (India)
  •  Merck KGaA(Germany)
  •  GENERAL ELECTRIC COMPANY (U.S.)
  • Thermo Fisher Scientific Inc (U.S.)
  • PerkinElmer Inc (India)
  • Tecan Trading AG (Switzerland)
  •  BD (U.S.)
  • Biotek Instruments Inc (U.S.)
  • Danaher(U.S.)
  • Bio-Rad Laboratories Inc
  •  F. Hoffmann-La Roche Ltd (U.S.)
  •  Cadmus Distribution Group Limited (U.S.)
  • Sysmex Corporation (Japan), Abbott (U.S.)
  • Agilent Technologies Inc (U.S.)
  • Siemens Healthcare Private Limited (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Cell Counting Devices Market will be worth USD 33 billion by 2030.
The Cell Counting Devices Market Growth Rate is 7.2% during the forecast period.
The Increasing research and development activities, Growing geriatric population, and High cost of cell counting devices: are the Growth Drivers of the Cell Counting Devices Market.
The product type, application, and end-user are the factors on which the Cell Counting Devices Market research is based
The Merck KGaA, a leading science and technology company, announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., U.S., to discover novel antibody-drug conjugates (ADCs) leveraging Mersana’s proprietary Immunosynthen STING-agonist ADC platform, directed against up to two targets and Abbott announced a series of new programs within its multi-million-dollar initiative to increase diversity in clinical trials and improve care among under-represented populations are the latest developments in the Cell Counting Devices Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials